Cryptocurrency NewsTop News

Bayer scraps U.S. plans to produce crop chemical blocked by court

imageStock Markets11 hours ago (Jun 16, 2020 07:20PM ET)

(C) Reuters. FILE PHOTO: The historic headquarters of German pharmaceutical and chemical maker Bayer AG is pictured in Leverkusen

CHICAGO (Reuters) – Bayer AG (DE:BAYGN) said on Tuesday it will scrap a nearly $1 billion project to produce the chemical dicamba in the United States, but said the move is unrelated to a federal court decision that blocked sales of weed killers based on the product.

The German-based company is moving to save cash as it wages an expensive legal battle to fight allegations that another product, its glyphosate-based weed killer Roundup, causes cancer. Bayer (OTC:BAYRY) denies the claims.

The company said it is halting work on a new dicamba plant in Luling, Louisiana, because global overcapacity for producing the chemical made the investment less attractive. Instead, Bayer will continue to buy dicamba and produce its XtendiMax herbicide at another plant in Iowa, according to a statement.

“Stopping construction enables us to preserve cash and prioritize our investments in new innovation for farmers,” Bayer said.

A three-judge panel of the 9th U.S. Circuit Court of Appeals ruled on June 3 that the U.S. Environmental Protection Agency substantially understated the risks related to the use of dicamba, which is sprayed on soybeans and cotton that Bayer genetically engineered to resist the chemical. The herbicides are known to drift away and damage other crops that are not resistant.

The EPA subsequently said farmers can use existing supplies of dicamba-based herbicides, which are also sold by rivals BASF SE (OTC:BASFY) and Corteva (NYSE:CTVA) Inc, until July 31.

“While the timing of the court’s ruling is coincidental and unfortunate, it was not a factor in our reassessment of the Luling plant,” Bayer said, adding that it still supports dicamba.

Monsanto (NYSE:MON), which Bayer bought for $63 billion two years ago, in 2015 announced preliminary plans to spend more than $1 billion over the next three to five years at its Luling site to produce dicamba. Bayer also inherited the legal dispute over glyphosate from the takeover.

Bayer scraps U.S. plans to produce crop chemical blocked by court

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles

Back to top button
Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!